	现金及等价物		日
AbbVie	USD 9.39B	4.16B	2026-03
Amgen	USD 12.04B	2.91B	2026-03
Anika Therapeutics	USD 41.02M	16.46M	2026-03
Arrowhead Research	USD 201.64M	112.94M	2025-12
AstraZeneca	USD 7.56B	1.85B	2026-03
BioCryst Pharmaceuticals	USD 171.59M	164.32M	2026-03
Biogen	USD 3.38B	374.2M	2026-03
Bristol-Myers Squibb	USD 9.57B	635M	2026-03
Enanta Pharmaceuticals	USD 37.44M	5.14M	2025-12
Gilead Sciences	USD 7.56B	234M	2025-12
GlaxoSmithKline	GBP 3.44B	292M	2026-03
Halozyme Therapeutics	USD 309.75M	175.93M	2026-03
Heron Therapeutics	USD 26.12M	2.53M	2026-03
Immunic	USD 186.63M	171.15M	2026-03
Incyte	USD 4.02B	435.22M	2026-03
Insmed	USD 582.19M	71.74M	2026-03
Ionis Pharmaceuticals	USD 1.92B	758M	2026-03
J&J	USD 21.69B	1.98B	2026-03
Karyopharm Therapeutics	USD 60.54M	22.87M	2025-12
Ligand Pharmaceuticals	USD 115.08M	59.85M	2026-03
Merck	USD 5.33B	9.24B	2026-03
Neurocrine Biosciences	USD 266.5M	446.5M	2026-03
Novartis	USD 6.88B	4.56B	2026-03
Novavax	USD 228.36M	12.27M	2026-03
Pfizer	USD 1.7B	561M	2026-03
PTC Therapeutics	USD 833.99M	150.66M	2026-03
Roche Holding	CHF 7.55B	579M	2025-06
Sarepta Therapeutics	USD 464.45M	336.83M	2026-03
Vertex Pharmaceuticals	USD 7.25B	638.6M	2026-03